The Research and Development team at Bavarian Nordic is focused on advancing the company's innovative cancer immunotherapies and infectious disease vaccines. This team conducts cutting-edge research, oversees preclinical studies, and collaborates on vaccine development while ensuring compliance with regulatory standards. Additionally, they support process development and technology transfer, working to optimize and enhance the efficacy and safety of the company’s products.
View all